The nostalgic feeling associated with doctors’ house calls reflects a classic one-to-one experience. However, today’s medical technology may have one-upped this approach through the emergence of “personalized medicine.” This new methodology relies on biomarkers to diagnose and establish treatment protocols based on each person’s unique characteristics. Furthermore, personalized medicine may transform the overall medical industry by enabling health-care providers to shift their emphasis from response to prevention.
Understanding the science behind personalized medicine is the subject of our most recent whitepaper titled “Biomarker. Molecular Detective: Personalized Medicine; the Next Generation of Diagnosis and Treatment” authored by OneBeacon Technology Risk Control Manager Mike Campbell. In this whitepaper, we explain biomarkers and how they can be used for detection and customized treatment, the FDA view, and the associated risks. You can also learn about our life sciences risk management capabilities on our website.